Abstract
BackgroundTumor‐derived microparticles (TMPs) are not only carriers for tumor antigens but also can be used as good delivery platform. Therefore, for such an excellent delivery platform, we considered modifying TMPs with lipopolysaccharide (LPS) and polyethyleneimine (PEI) to synthesize TMPs-PEI-LPS for the delivery of tumor antigen and investigated its delivery efficiency, histocompatibility and anti-tumor effect. ResultWe investigated the bioactivity of TMPs-PEI-LPS with dendritic cells and their potential for therapeutic application to treat lung cancer in mice models bearing Lewis lung carcinoma cells. Both in vitro and in vivo assays demonstrated successful TMPs-PEI-LPS induced the uptake and maturity of dendritic cells. TMPs-PEI-LPS exhibited certain immunostimulation activity and anti-tumor effects on inhibiting tumor growth in vivo. Notably, TMPs-PEI-LPS were safe and non-toxic in vivo study. ConclusionThese results indicated that TMPs-PEI-LPS are promising platforms for delivering tumor antigens to enhance immunogenicity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
